2012-06-15 09:22:36 - Recently published research from Global Markets Direct, "Orexo AB - Product Pipeline Review - 2012", is now available at Fast Market Research

Global Market Direct's pharmaceuticals report, "Orexo AB - Product Pipeline Review - 2012" provides data on the Orexo AB's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Orexo AB's corporate website, SEC filings, investor presentations and featured press releases, both from Orexo AB and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Orexo AB - Brief Orexo AB overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Orexo AB human therapeutic division.
* Overview of pipeline therapeutics

across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Orexo AB with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Orexo AB's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/398831_orexo_ab_product_pipeline_review_2012 ..


Reasons to buy

* Evaluate Orexo AB's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Orexo AB in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Orexo AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Orexo AB.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Orexo AB and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Orexo AB; Orexo AB - Key Therapeutics; Orexo AB - Pipeline Overview and Promising Molecules; Orexo AB - News; Orexo AB - Latest Updates; Orexo AB - Pipeline; Orexo AB - Discontinued/Dormant Projects

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Orexo AB Snapshot
Orexo AB Overview
Key Information
Key Facts
Orexo AB - Research and Development Overview
Key Therapeutic Areas
Orexo AB - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Orexo AB - Pipeline Products Glance
Orexo AB - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Orexo AB Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Orexo AB - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Orexo AB - Drug Profiles
OX-2477
Product Description
Mechanism of Action
R&D Progress
OX17
Product Description
Mechanism of Action
R&D Progress
OX219
Product Description
Mechanism of Action
R&D Progress
OX27
Product Description
Mechanism of Action
R&D Progress
OX30
Product Description
Mechanism of Action
R&D Progress
OX51
Product Description
Mechanism of Action
R&D Progress
OX641
Product Description
Mechanism of Action
R&D Progress
Orexo AB - Pipeline Analysis
Orexo AB - Pipeline Products by Therapeutic Class
Orexo AB - Pipeline Products By Target
Orexo AB - Pipeline Products by Route of Administration
Orexo AB - Pipeline Products By Mechanism of Action
Orexo AB - Recent Pipeline Updates
Orexo AB - Dormant Projects
Orexo AB - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
OX-CLI
OX-ESI
OX914
Pharmos Corporation - Company Statement
Pharmos Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Pharmos Corporation, Recent Developments
Pharmos Corporation- Press Release
May 03, 2012: Orexo Presents Plans To Accelerate Development Of OX219
Mar 24, 2009: Orexo Announces Clinical Results From An Experimental Phase IIa Study Of OX914
Financial Deals Landscape
Orexo AB, Deals Summary
Orexo AB, Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Biolipox Acquires Research And Development Assets From Inflazyme Pharma
Venture Financing
PharmaKodex Secures $13.43 Million In Series A Financing
Biolipox Secures $41 Million In Series C Financing
Partnerships
Orexo Extends Licensing Agreement With Boehringer
Orexo Enters Into A Co-Development Agreement With Healthcare Company
Orexo Enters Into Co-Marketing Agreement With Hospira
ProStrakan Forms Joint Venture With Orexo
Gedeon Richter Enters Into A Distribution Agreement With Orexo
Doxa Enters Into Co-Development Agreement With Orexo
Licensing Agreements
Orexo Enters Into Licensing Agreement With NovaMed
Orexo Enters Into Licensing Agreement With Invida Group For Abstral
Orexo Enters Into Licensing Agreement With NewBridge Pharma For Abstral
Orexo Enters Into Licensing Agreement With Ortho-McNeil-Janssen And Janssen Pharmaceutica
Orexo Enters Into Licensing Agreement With Novartis Pharma
Orexo Extends Its Licensing Agreement With ProStrakan
ProStrakan Enters Into Licensing Agreement With Orexo
Orexo Enters Into Licensing Agreement With Boehringer Ingelheim

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=398831&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.